GLP-1 Medications: What Ozempic Is Actually Doing to Your Body
Ozempic and Wegovy aren't just weight loss drugs. The 2024 SELECT trial showed 20% fewer heart attacks. The FLOW trial was stopped early due to kidney prot
Key Findings
- The 2024 SELECT trial (17,600 patients) found semaglutide reduced major cardiovascular events by 20% in people with obesity — independent of weight loss achieved
- The landmark FLOW trial was halted early in 2024 after semaglutide showed a 24% reduction in kidney failure events and 16% reduction in kidney failure risk
- FDA approved Wegovy in March 2024 specifically for cardiovascular risk reduction — not just weight management
- GLP-1 receptors are found in the brain, heart, kidneys, liver, gut, and pancreas — explaining why these drugs have effects far beyond appetite suppression
- A 2024 study found semaglutide users show neurological changes associated with reduced cravings for alcohol, opioids, and compulsive behaviors — independent of their weight loss goals
Key Nutrients
- Methylcobalamin (Active B12) — GLP-1 drugs slow gastric emptying which reduces B12 absorption — the active (methylated) form is essential for long-term users since it doesn't require conversion
- Magnesium — Nausea and reduced food intake can lead to low magnesium; deficiency amplifies metabolic dysfunction
- Zinc — Reduced appetite and food intake may compromise zinc status, which is central to insulin signaling
- Protein (leucine-rich sources) — Muscle preservation is a critical concern — adequate protein (1.2–1.6g/kg) is essential to prevent GLP-1-driven lean mass loss
- Vitamin D — Obesity is strongly associated with vitamin D deficiency; improving metabolic function may shift requirements
The Bottom Line
GLP-1 receptor agonists are genuinely novel in medicine — they work on biology most drugs don't touch. The cardiovascular and kidney data is compelling and real. But so are the practical considerations: muscle loss, nutrient depletion from reduced food intake, and what happens when you stop. Understanding the full picture is what separates a good outcome from a complicated one.
Related Topics
- Medications That Deplete Nutrients
- Peptides and the Access Debate
- Chronic Inflammation — The Hidden Driver of Disease
- Gut Health and Nutrient Absorption
- Does Metformin Deplete B12?